ÃâÒßѧÊÔÌâ
6E(..fo:" Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
+Fh,!` 1. Fas(CD95)/FasL
gA3f@7}d 2. common chain of cytokine receptor
LlVbY=EX7 3 . TCR/CD3 complex
g_?Q3 4. negaive selection of thymocytes
:"b :uQ 5. artificial active immune
2^nws 6. anti-idiotypic
QjYw^[o 7. IgSF
,p!IFS` 8. Integrin
Vock19P 9. chemokine
ml!c0< 10. B7/CD28
x|()f3{. ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
P8;1,?ou 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
+oHbAPs8 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
=)*ZrD 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
)HvBceN 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
6Tc!=lk
w@n}DCFt 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
\+0l#t$ µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
z+CX$.Z Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
<Of-,PcCV 1. B7/CD28
wM3m'# xJ 2. Th1 subset
}U4mXkZF 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
xO,;4uE 4. antibody affinity maturation
?{5}3abB` 5. AP-1
yNU}1_oK 6. single chain variable fragment£¨ScFv£©
R|``A5zQ 7. NK cell receptor
o|#F@L3i 8. Zinkernagel-Doherty phenomenon
/E i e5p 9. Ig fold
'C#[iRG4 10. CD40/CD40L
BMV\@Sg ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
]&`=p{Z 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
M-q5Jfm 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
t~) g)=> 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
KGI<G Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
ZvO1=*
J, 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
{))Cb9' 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
_={mKKoHs 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
y7GgTC/H Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
'T3xZ?*q= £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
EQ|Wke Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
"*(a2k3J 1.Co-stimulators (or co-stimulating molecules)
6K=}n] n 2.NK-kB
@L0)k^: 3.Immunoglobulin superfamily
8s-X
H 4.antigen-presenting cell (APC)
!C^>tmqS 5.death domain
*&
R|0I{> 6.CCR and CXCR
BqA_CW 7.Lectin (or mitogen)
9RkNRB)8 8.Clusters of differentiation, CD)
,Tk53 " 9.B7 family
#YK3Ogb, 10.Cytotoxic T lymphocyte, CTL)
fE3%$M[V7 11.IL-15 and IL-15 receptor (IL-15R)
yUO%@; 12.MHC restriction
:m/qR74+" 13.Affinity-chromatography
h
]&~yuI> 14.Cyctosprin A, CsA
I{.t-3hp 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
/V#?d ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
*O)i)[" 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
1&9w]\Ae7l 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
hb)C"q= 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
MIWc
@.i2 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
s|TO9N)pO ÃâÒßѧרҵ£º
b' ~WS4xlD 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
eYUq0~3 Ïû»¯ÄÚ¿Æ£º
\0 &$n 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
~lqNWL^l ѪҺ²¡Ñ§×¨Òµ£º
z92Xc 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
Ol|fdQ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
S?VKzVDB.S (רҵ»ù´¡: ÃâÒßѧ)
BJ
fBYH,M Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
LCq1F(q 1. ADCC(antibody dependent cell-mediated cytotoxicity)
L;+e)I] 2. »·æß¾úËØ(cyclosporin)
lZ <D,& 3. KIR(killer cell inhibitory receptor)
C 20VSwd 4. HLDA(human leucocyte differentiation antigen)
TB84} 5. Interleukin 18(IL-18)
B8!$?1*^a 6. ÕûºÏËØ(integrin)
L6ypn)l 7. Fas/FasL
?MFXZ/3(ba 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
t? =V<Yd1 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
Ke~!1S8= 10. Th1/Th2
VD =f 'D 11. »ùÒòÒßÃç(DNAÒßÃç)
=2vZqGO30 12. chemokines and chemokine receptor
Uv=)y^H~*A 13. ÃâÒßÄÍÊÜ
<dz_7hR" 14. ¹²´Ì¼¤·Ö×Ó
WE-+WC!!: 15. ËÀÍö½á¹¹Óò(death domain)
A.r.tf}: ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
j)juvat 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
RK)ikLgp 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
LJt5?zQKrW £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
<7/7+_y £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
:r{W)(mm £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
/1= x8Sb £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
%O7?:#_ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
'[HU!8F Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
* )HVK&